BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 9229202)

  • 1. Prostate cancer incidence and mortality rates among white and black men.
    Merrill RM; Brawley OW
    Epidemiology; 1997 Mar; 8(2):126-31. PubMed ID: 9229202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in prostate cancer mortality among black men and white men in the United States.
    Chu KC; Tarone RE; Freeman HP
    Cancer; 2003 Mar; 97(6):1507-16. PubMed ID: 12627516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer surveillance series: interpreting trends in prostate cancer--part I: Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates.
    Hankey BF; Feuer EJ; Clegg LX; Hayes RB; Legler JM; Prorok PC; Ries LA; Merrill RM; Kaplan RS
    J Natl Cancer Inst; 1999 Jun; 91(12):1017-24. PubMed ID: 10379964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate cancer: trends in mortality and stage-specific incidence rates by racial/ethnic group in Los Angeles County, California (United States).
    Danley KL; Richardson JL; Bernstein L; Langholz B; Ross RK
    Cancer Causes Control; 1995 Nov; 6(6):492-8. PubMed ID: 8580296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The lifetime risk of developing prostate cancer in white and black men.
    Merrill RM; Weed DL; Feuer EJ
    Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):763-8. PubMed ID: 9332756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Black-white differences in survival from late-stage prostate cancer.
    Polednak AP
    Ethn Dis; 2003; 13(2):220-5. PubMed ID: 12785419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Racial disparities in late-stage prostate cancer: a SEER analysis 2005-2015.
    Rodriguez S; Sparks AD; Zhou H; Amdu RL; Lin J
    Can J Urol; 2019 Oct; 26(5):9946-9951. PubMed ID: 31629445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Race, treatment, and long-term survival from prostate cancer in an equal-access medical care delivery system.
    Optenberg SA; Thompson IM; Friedrichs P; Wojcik B; Stein CR; Kramer B
    JAMA; 1995 Nov 22-29; 274(20):1599-605. PubMed ID: 7474244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Explaining the difference in prostate cancer mortality rates between white and black men in the United States.
    Merrill RM; Lyon JL
    Urology; 2000 May; 55(5):730-5. PubMed ID: 10792091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rising incidence of renal cell cancer in the United States.
    Chow WH; Devesa SS; Warren JL; Fraumeni JF
    JAMA; 1999 May; 281(17):1628-31. PubMed ID: 10235157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Removal of the financial barrier to health care: does it impact on prostate cancer at presentation and survival? A comparative study between black and white men in a Veterans Affairs system.
    Powell IJ; Schwartz K; Hussain M
    Urology; 1995 Dec; 46(6):825-30. PubMed ID: 7502424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stage at diagnosis of prostate cancer in Connecticut by poverty and race.
    Polednak AP
    Ethn Dis; 1997; 7(3):215-20. PubMed ID: 9467704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in the stage specific incidence of prostate carcinoma in the Detroit metropolitan area, 1973-1994.
    Schwartz KL; Severson RK; Gurney JG; Montie JE
    Cancer; 1996 Sep; 78(6):1260-6. PubMed ID: 8826949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in the Incidence of Fatal Prostate Cancer in the United States by Race.
    Kelly SP; Rosenberg PS; Anderson WF; Andreotti G; Younes N; Cleary SD; Cook MB
    Eur Urol; 2017 Feb; 71(2):195-201. PubMed ID: 27476048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging and widening colorectal carcinoma disparities between Blacks and Whites in the United States (1975-2002).
    Irby K; Anderson WF; Henson DE; Devesa SS
    Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):792-7. PubMed ID: 16614125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Racial Disparities and Trends in Pancreatic Cancer Incidence and Mortality in the United States.
    Tavakkoli A; Singal AG; Waljee AK; Elmunzer BJ; Pruitt SL; McKey T; Rubenstein JH; Scheiman JM; Murphy CC
    Clin Gastroenterol Hepatol; 2020 Jan; 18(1):171-178.e10. PubMed ID: 31202981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spatial patterns of localized-stage prostate cancer incidence among white and black men in the southeastern United States, 1999-2001.
    Altekruse SF; Huang L; Cucinelli JE; McNeel TS; Wells KM; Oliver MN
    Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1460-7. PubMed ID: 20501756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Black versus white racial differences in clinical stage at diagnosis and treatment of prostatic cancer in Connecticut.
    Polednak AP; Flannery JT
    Cancer; 1992 Oct; 70(8):2152-8. PubMed ID: 1394045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate Cancer Incidence and PSA Testing Patterns in Relation to USPSTF Screening Recommendations.
    Jemal A; Fedewa SA; Ma J; Siegel R; Lin CC; Brawley O; Ward EM
    JAMA; 2015 Nov; 314(19):2054-61. PubMed ID: 26575061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate cancer survival in the United States by race and stage (2001-2009): Findings from the CONCORD-2 study.
    Steele CB; Li J; Huang B; Weir HK
    Cancer; 2017 Dec; 123 Suppl 24(Suppl 24):5160-5177. PubMed ID: 29205313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.